Imiquimod
NDC 87519-004, Imiquimod, cream, from Anvi Pharmaceuticals Inc..
- Product NDC
- 87519-004
- Status
- Listed
- Labeler
- Anvi Pharmaceuticals Inc.
- Dosage form
- CREAM
- Route
- TOPICAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205971
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/87519-004 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IMIQUIMOD37.5 mg/g
Pharmacologic classes
Increased Cytokine Activity [PE]; Increased Cytokine Production [PE]; Interferon Inducers [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 87519-004-75 | 87519000475 | 1 BOTTLE, PUMP in 1 CARTON (87519-004-75) / 7.5 g in 1 BOTTLE, PUMP |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5c19b687-fd29-b22e-e063-6294a90ad67b
Use it
Look up 87519-004 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/87519-004 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 87519-004. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.